Journal of AIDS & Clinical Research

In the battle against HIV/AIDS, health education campaigns play a crucial role in promoting awareness, prevention, and reducing stigma. Evaluating the impact of such campaigns is essential to ensure their effectiveness and guide future interventions. One method that can be employed for evaluation is the Analytical Hierarchy Process (AHP). AHP provides a structured framework for decision-making and enables the systematic comparison of multiple criteria and alternatives. This article explores the application of the AHP method in evaluating the impact of an HIV health education campaign, highlighting its advantages and discussing the key considerations for implementation.

HIV infection is a global health concern that not only compromises the immune system but also increases the risk of developing malignancies. People Living With HIV (PLWH) are more susceptible to certain types of cancers, collectively referred to as HIV-associated malignancies. The mechanisms underlying the development of these malignancies in the context of HIV infection are complex and multifactorial. Understanding the oncogenic pathways involved and identifying potential biomarkers is crucial for translational research and the development of targeted therapies. This article provides a comprehensive overview of the mechanisms underlying HIV-associated malignancies and highlights the role of oncogenic proteomics in advancing translational research.

Life expectancy is a key indicator of population health and serves as a measure of overall well-being. In French Guiana, an overseas department of France located on the northeastern coast of South America, life expectancy has shown significant disparities between males and females. This article explores the complex sex differences in life expectancy in French Guiana, examining the factors contributing to these disparities and discussing potential strategies for addressing them. It highlights the importance of understanding the underlying causes and implementing targeted interventions to improve population health outcomes.

Diffuse Large B-cell Lymphoma (DLBCL) is the most common type of Non-Hodgkin Lymphoma (NHL) and is known to have a higher incidence among People Living With HIV (PLWH). The interplay between HIV infection and the immune system, along with the presence of other co-infections and chronic inflammation, creates a unique environment that promotes the development of DLBCL. This article delves into the relationship between the HIV environment and DLBCL, discussing the underlying mechanisms, risk factors, and potential therapeutic approaches. Understanding the complex interactions between HIV and DLBCL is crucial for optimizing patient management and improving outcomes in this population.